Year |
Citation |
Score |
2023 |
Werba G, Weissinger D, Kawaler EA, Zhao E, Kalfakakou D, Dhara S, Wang L, Lim HB, Oh G, Jing X, Beri N, Khanna L, Gonda T, Oberstein P, Hajdu C, ... ... Simeone DM, et al. Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment. Nature Communications. 14: 797. PMID 36781852 DOI: 10.1038/s41467-023-36296-4 |
0.31 |
|
2022 |
Pan S, Lai LA, Simeone DM, Dawson DW, Yan Y, Crnogorac-Jurcevic T, Chen R, Brentnall TA. Proteomes of Extracellular Vesicles From Pancreatic Cancer Cells and Cancer-Associated Fibroblasts. Pancreas. 51: 790-799. PMID 36395405 DOI: 10.1097/MPA.0000000000002115 |
0.37 |
|
2022 |
Xu J, Yang R, Li J, Wang L, Cohen M, Simeone DM, Costa M, Wu XR. DNMT3A//Rac1 Is an Effector Pathway for to Drive Stem-Cell-like and Invasive Behaviors of Advanced Bladder Cancer Cells. Cancers. 14. PMID 36077697 DOI: 10.3390/cancers14174159 |
0.3 |
|
2021 |
Gonda TA, Farrell J, Wallace M, Khanna L, Janec E, Kwon R, Saunders M, Siddiqui U, Brand R, Simeone D. Standardization of EUS imaging and reporting in high-risk individuals of pancreatic adenocarcinoma: consensus statement of the Pancreatic Cancer Early Detection Consortium (PRECEDE). Gastrointestinal Endoscopy. PMID 34736932 DOI: 10.1016/j.gie.2021.10.025 |
0.306 |
|
2021 |
Gonda TA, Everett JN, Wallace M, Simeone DM. Recommendations for a More Organized and Effective Approach to the Early Detection of Pancreatic Cancer From the PRECEDE (Pancreatic Cancer Early Detection) Consortium. Gastroenterology. 161: 1751-1757. PMID 34454916 DOI: 10.1053/j.gastro.2021.08.036 |
0.319 |
|
2021 |
Purohit V, Wang L, Yang H, Li J, Ney GM, Gumkowski ER, Vaidya AJ, Wang A, Bhardwaj A, Zhao E, Dolgalev I, Zamperone A, Abel EV, Magliano MPD, Crawford HC, ... ... Simeone DM, et al. ATDC binds to KEAP1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancer. Genes & Development. PMID 33446568 DOI: 10.1101/gad.344184.120 |
0.319 |
|
2020 |
Grant RC, Denroche R, Jang GH, Nowak KM, Zhang A, Borgida A, Holter S, Topham JT, Wilson J, Dodd A, Jang R, Prince R, Karasinska JM, Schaeffer DF, Wang Y, ... ... Simeone D, et al. Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma. Gut. PMID 32933947 DOI: 10.1136/Gutjnl-2020-320730 |
0.337 |
|
2020 |
Gout J, Perkhofer L, Morawe M, Arnold F, Ihle M, Biber S, Lange S, Roger E, Kraus JM, Stifter K, Hahn SA, Zamperone A, Engleitner T, Müller M, Walter K, ... ... Simeone DM, et al. Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer. Gut. PMID 32873698 DOI: 10.1136/Gutjnl-2019-319970 |
0.339 |
|
2020 |
Grossberg AJ, Chu LC, Deig CR, Fishman EK, Hwang WL, Maitra A, Marks DL, Mehta A, Nabavizadeh N, Simeone DM, Weekes CD, Thomas CR. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. Ca: a Cancer Journal For Clinicians. PMID 32683683 DOI: 10.3322/Caac.21626 |
0.339 |
|
2020 |
Brunton H, Caligiuri G, Cunningham R, Upstill-Goddard R, Bailey UM, Garner IM, Nourse C, Dreyer S, Jones M, Moran-Jones K, Wright DW, Paulus-Hock V, Nixon C, Thomson G, Jamieson NB, ... ... Simeone DM, et al. HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer. Cell Reports. 31: 107625. PMID 32402285 DOI: 10.1016/J.Celrep.2020.107625 |
0.378 |
|
2019 |
Wan S, Kim TH, Smith KJ, Delaney R, Park GS, Guo H, Lin E, Plegue T, Kuo N, Steffes J, Leu C, Simeone DM, Razimulava N, Parikh ND, Nagrath S, et al. New Labyrinth Microfluidic Device Detects Circulating Tumor Cells Expressing Cancer Stem Cell Marker and Circulating Tumor Microemboli in Hepatocellular Carcinoma. Scientific Reports. 9: 18575. PMID 31819089 DOI: 10.1038/S41598-019-54960-Y |
0.334 |
|
2019 |
Majumder S, Taylor WR, Yab TC, Berger CK, Dukek BA, Cao X, Foote PH, Wu CW, Mahoney DW, Aslanian HR, Fernández-Del Castillo C, Doyle LA, Farrell JJ, Fisher WE, Lee LS, ... ... Simeone DM, et al. Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing. The American Journal of Gastroenterology. PMID 31306149 DOI: 10.14309/Ajg.0000000000000284 |
0.382 |
|
2019 |
Bulin AL, Broekgaarden M, Simeone D, Hasan T. Low dose photodynamic therapy harmonizes with radiation therapy to induce beneficial effects on pancreatic heterocellular spheroids. Oncotarget. 10: 2625-2643. PMID 31080554 DOI: 10.18632/Oncotarget.26780 |
0.35 |
|
2019 |
Pratt ED, Cowan RW, Manning SL, Qiao E, Cameron H, Schradle K, Simeone DM, Zhen DB. Multiplex Enrichment and Detection of Rare KRAS Mutations in Liquid Biopsy Samples using Digital Droplet Pre-Amplification. Analytical Chemistry. 91: 7516-7523. PMID 31072097 DOI: 10.1021/Acs.Analchem.8B01605 |
0.302 |
|
2019 |
Palmbos PL, Wang Y, Bankhead Iii A, Kelleher AJ, Wang L, Yang H, Ahmet ML, Gumkowski ER, Welling SD, Magnuson B, Leflein J, Lorenzatti Hiles G, Abel EV, Dziubinski ML, Urs S, ... ... Simeone DM, et al. ATDC mediates a TP63-regulated basal cancer invasive program. Oncogene. PMID 30643195 DOI: 10.1038/S41388-018-0646-9 |
0.398 |
|
2019 |
Wang A, Zamperone A, Sohail M, Wang L, Balogun F, Li J, Zhao E, Diolaiti D, Sfeir A, Simeone DM. Abstract I14: Polymerase theta synthetic lethal interaction in homologous recombination-deficient pancreatic ductal adenocarcinoma Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-I14 |
0.387 |
|
2019 |
Fernandez-Zapico M, Kim DW, Philip P, Vandell A, Eckard J, Korn R, Priore GD, Simeone D. Abstract B15: Therapeutic potential of targeting amino acid metabolism in pancreatic cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-B15 |
0.446 |
|
2018 |
Wang Y, Day ML, Simeone DM, Palmbos PL. 3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer. Journal of Visualized Experiments : Jove. PMID 30272657 DOI: 10.3791/58345 |
0.43 |
|
2018 |
Maust JD, Frankowski-McGregor CL, Bankhead A, Simeone DM, Sebolt-Leopold JS. Cyclooxygenase-2 Influences Response to Cotargeting of MEK and CDK4/6 in a Subpopulation of Pancreatic Cancers. Molecular Cancer Therapeutics. 17: 2495-2506. PMID 30254182 DOI: 10.1158/1535-7163.Mct-18-0082 |
0.459 |
|
2018 |
Abel EV, Goto M, Magnuson B, Abraham S, Ramanathan N, Hotaling E, Alaniz AA, Kumar-Sinha C, Dziubinski ML, Urs S, Wang L, Shi J, Waghray M, Ljungman M, Crawford HC, ... Simeone DM, et al. HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties. Elife. 7. PMID 30074477 DOI: 10.7554/Elife.33947 |
0.342 |
|
2018 |
Zeinali M, Murlidhar V, Fouladdel S, Hafner M, Shao S, Zhao L, Cameron H, Bankhead AI, Shi J, Cuneo KC, Sahai V, Azizi E, Wicha MS, Simeone DM, Nagrath S. Abstract 5579: Increased number of EMT-like CTCs relative to epithelial CTCs reveals signatures of poor outcomes in pancreatic cancer Cancer Research. 78: 5579-5579. DOI: 10.1158/1538-7445.Am2018-5579 |
0.433 |
|
2017 |
Picozzi V, Sahai V, Simeone D, Rocha Lima C, Ocean A, Philip P, Saif W, Kalyan A, Ondovik M, Shiansong Li J, Louis C. A phase 1/2 study of metronomic 5-fluorouracil (5-FU) plus nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin (FABLOx) in patients with metastatic pancreatic cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 28: iii81-iii82. PMID 32136032 DOI: 10.1093/Annonc/Mdx261.229 |
0.422 |
|
2017 |
Pal A, Dziubinski M, Di Magliano MP, Simeone DM, Owens S, Thomas D, Peterson L, Potu H, Talpaz M, Donato NJ. Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth. Neoplasia (New York, N.Y.). 20: 152-164. PMID 29248719 DOI: 10.1016/J.Neo.2017.11.007 |
0.408 |
|
2017 |
Lin E, Rivera-Báez L, Fouladdel S, Yoon HJ, Guthrie S, Wieger J, Deol Y, Keller E, Sahai V, Simeone DM, Burness ML, Azizi E, Wicha MS, Nagrath S. High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor Cells. Cell Systems. PMID 28941584 DOI: 10.1016/J.Cels.2017.08.012 |
0.374 |
|
2017 |
Jack R, Hussain K, Rodrigues D, Zeinali M, Azizi E, Wicha M, Simeone DM, Nagrath S. Microfluidic continuum sorting of sub-populations of tumor cells via surface antibody expression levels. Lab On a Chip. PMID 28294230 DOI: 10.1039/C6Lc01496H |
0.392 |
|
2017 |
Cuneo KC, Morgan M, Schipper MJ, Maybaum J, Al-Hawary M, Simeone DM, Sahai V, Zalupski M, Lawrence TS. Phase I study of definitive chemoradiation with gemcitabine and the WEE1 inhibitor AZD1775 in unresectable pancreatic cancer. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.4_Suppl.Tps512 |
0.438 |
|
2017 |
Everett J, Schradle K, Cameron H, Patel A, Koeppe E, Stoffel EM, Simeone DM. Effectiveness of tablet family history collection in a multidisciplinary pancreatic tumor clinic in identifying patients with risk factors for hereditary cancer. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E13020 |
0.386 |
|
2017 |
Majumder S, Taylor WR, Yab TC, Berger CK, Dukek BA, Cao X, Foote PH, Mahoney DW, Aslanian HR, Doyle L, Farrell JJ, Fisher WE, Lee LS, Lee YN, Park WG, ... ... Simeone DM, et al. Novel DNA Methylation Markers Assayed from Cyst Fluid Accurately Detect Advanced Neoplasia in Pancreatic Cysts: A Multicenter Study Gastroenterology. 152. DOI: 10.1016/S0016-5085(17)30821-1 |
0.315 |
|
2016 |
Wilson RH, Chandra M, Scheiman JM, Lee SY, Lee OE, McKenna BJ, Simeone DM, Taylor JM, Mycek MA. Tissue Classification Using Optical Spectroscopy Accurately Differentiates Cancer and Chronic Pancreatitis. Pancreas. PMID 27861201 DOI: 10.1097/Mpa.0000000000000732 |
0.412 |
|
2016 |
Jack RM, Grafton MM, Rodrigues D, Giraldez MD, Griffith C, Cieslak R, Zeinali M, Kumar Sinha C, Azizi E, Wicha M, Tewari M, Simeone DM, Nagrath S. Ultra-Specific Isolation of Circulating Tumor Cells Enables Rare-Cell RNA Profiling. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 3: 1600063. PMID 27711257 DOI: 10.1002/Advs.201600063 |
0.357 |
|
2016 |
Miller MS, Allen P, Brentnall TA, Goggins M, Hruban RH, Petersen GM, Rao CV, Whitcomb DC, Brand RE, Chari ST, Klein AP, Lubman DM, Rhim AD, Simeone DM, Wolpin BM, et al. Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report. Pancreas. 45: 1080-91. PMID 27518363 DOI: 10.1097/Mpa.0000000000000705 |
0.449 |
|
2016 |
Zhen DB, Griffith KA, Ruch JM, Camphausen K, Savage JE, Kim EJ, Sahai V, Simeone DM, Zalupski MM. A phase I trial of cabozantinib and gemcitabine in advanced pancreatic cancer. Investigational New Drugs. PMID 27439894 DOI: 10.1007/S10637-016-0376-1 |
0.319 |
|
2016 |
Zhang Y, Velez-Delgado A, Mathew E, Li D, Mendez FM, Flannagan K, Rhim AD, Simeone DM, Beatty GL, Pasca di Magliano M. Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer. Gut. PMID 27402485 DOI: 10.1136/Gutjnl-2016-312078 |
0.372 |
|
2016 |
Nagrath S, Jack RM, Sahai V, Simeone DM. Opportunities and Challenges for Pancreatic Circulating Tumor Cells Gastroenterology. 151: 412-426. PMID 27339829 DOI: 10.1053/J.Gastro.2016.05.052 |
0.44 |
|
2016 |
Coveler AL, Herman JM, Simeone DM, Chiorean EG. Localized Pancreatic Cancer: Multidisciplinary Management. American Society of Clinical Oncology Educational Book / Asco. American Society of Clinical Oncology. Meeting. 35: e217-26. PMID 27249726 DOI: 10.14694/EDBK_160827 |
0.31 |
|
2016 |
Waghray M, Yalamanchili M, Dziubinski M, Zeinali M, Erkkinen M, Yang H, Schradle KA, Urs S, Pasca Di Magliano M, Welling TH, Palmbos PL, Abel EV, Sahai V, Nagrath S, Wang L, ... Simeone DM, et al. GM-CSF Mediates Mesenchymal-Epithelial Crosstalk in Pancreatic Cancer. Cancer Discovery. PMID 27184426 DOI: 10.1158/2159-8290.Cd-15-0947 |
0.43 |
|
2016 |
Kwon RS, Young BE, Marsteller WF, Lawrence C, Wu BU, Lee LS, Mullady D, Klibansky DA, Gardner TB, Simeone DM. Narcotic Independence After Pancreatic Duct Stenting Predicts Narcotic Independence After Lateral Pancreaticojejunostomy for Chronic Pancreatitis. Pancreas. PMID 27088488 DOI: 10.1097/Mpa.0000000000000623 |
0.321 |
|
2016 |
Majumder S, Taylor WR, Yab TC, Berger CK, Mahoney DW, Aslanian HR, Farrell JJ, Fisher WE, Rothberg BG, Salem RR, Simeone DM, Buren GJV, Raimondo M, Chari ST, Kisiel JB, et al. Detection of Advanced Neoplasia in Pancreatic Cysts by Assay of Novel DNA Methylation Markers in Cyst Fluid: A Multicenter Pilot Study: 2016 ACG Fellows-In-Training Award (Biliary/Pancreas Category): 2 The American Journal of Gastroenterology. 111. DOI: 10.14309/00000434-201610001-00002 |
0.312 |
|
2016 |
Zhen DB, Griffith KA, Ruch JM, Morgan M, Kim EJ, Sahai V, Simeone DM, Zalupski M. A phase I trial of cabozantinib (XL184) and gemcitabine in advanced pancreatic cancer. Journal of Clinical Oncology. 34: 334-334. DOI: 10.1200/Jco.2016.34.4_Suppl.334 |
0.334 |
|
2016 |
Zhang Y, Velez-Delgado A, Mathew E, Li D, Mendez FM, Flannagan K, Rhim AD, Simeone DM, Beatty GL, Magliano MPd. Abstract A096: Myeloid cells are required for pancreatic carcinogenesis and PD-1/PD-L1 checkpoint activation Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-A096 |
0.431 |
|
2016 |
Schradle KA, Cameron HG, Kumar R, Koeppe E, Leflein E, Moisa C, Demerath M, Stoffel EM, Simeone DM. Abstract A11: Assessment of family cancer history in a pancreatic cancer clinic: A pilot study of a web-based survey Cancer Research. 76. DOI: 10.1158/1538-7445.Panca16-A11 |
0.381 |
|
2016 |
Rivera-Baez L, Lin E, Waghray M, Fouladdel S, Azizi E, Wicha M, Sahai V, Simeone D, Nagrath S. Abstract A10: Biomarker independant microfluidic Labyrinth for the high throughput enrichment and characterization of circulating tumor cells in pancreatic cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Panca16-A10 |
0.496 |
|
2016 |
Cuneo KC, Morgan M, Schipper MJ, Maybaum J, Feng MU, Al-Hawary M, Simeone DM, Olson LD, Sahai V, Zalupski M, Lawrence TS. Abstract CT035: A dose escalation trial of the WEE1 inhibitor AZD1775, gemcitabine, and concurrent radiation in locally advanced pancreatic cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Ct035 |
0.381 |
|
2016 |
Lin E, Rivera L, Fouladdel S, Yoon HJ, Guthrie S, Weiner J, Deol YS, Keller E, Sahai V, Simeone DM, Burness ML, Azizi E, Wicha MS, Nagrath S. Abstract 3307: Label-free high throughput microfluidic device for the isolation and single cell multiplex gene expression analysis of circulating tumor cells from breast cancer patients Cancer Research. 76: 3307-3307. DOI: 10.1158/1538-7445.Am2016-3307 |
0.406 |
|
2016 |
Maust JD, Simeone D, Sebolt-Leopold J. Abstract 3018: Cotargeting MEK and CDK4/6 to treat pancreatic adenocarcinoma Cancer Research. 76: 3018-3018. DOI: 10.1158/1538-7445.Am2016-3018 |
0.434 |
|
2015 |
Palmbos PL, Wang L, Yang H, Wang Y, Leflein J, Ahmet ML, Wilkinson JE, Kumar-Sinha C, Ney G, Tomlins SA, Daignault SD, Kunju LP, Wu XR, Lotan Y, Liebert M, ... ... Simeone DM, et al. ATDC (TRIM29) Drives Invasive Bladder Cancer Formation. Cancer Research. PMID 26471361 DOI: 10.1158/0008-5472.Can-15-0603 |
0.399 |
|
2015 |
Zhou J, Fang CX, Shen J, Schipper MJ, Zalupski MM, Minter RM, Simeone DM, Hart D, Eagle T, Kimmel GW, Vainshtein J, Lawrence TS, Feng M. Definitive Chemoradiation With Full-dose Gemcitabine for Unresectable Pancreatic Cancer: Efficacy of Involved-Field Radiotherapy. American Journal of Clinical Oncology. PMID 26165418 DOI: 10.1097/Coc.0000000000000200 |
0.43 |
|
2015 |
Bednar F, Schofield HK, Collins MA, Yan W, Zhang Y, Shyam N, Eberle JA, Almada LL, Olive KP, Bardeesy N, Fernandez-Zapico ME, Nakada D, Simeone DM, Morrison SJ, Pasca di Magliano M. Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism. Carcinogenesis. PMID 25939753 DOI: 10.1093/Carcin/Bgv058 |
0.464 |
|
2015 |
Chari ST, Kelly K, Hollingsworth MA, Thayer SP, Ahlquist DA, Andersen DK, Batra SK, Brentnall TA, Canto M, Cleeter DF, Firpo MA, Gambhir SS, Go VL, Hines OJ, Kenner BJ, ... ... Simeone DM, et al. Early Detection of Sporadic Pancreatic Cancer: Summative Review. Pancreas. 44: 693-712. PMID 25931254 DOI: 10.1097/Mpa.0000000000000368 |
0.386 |
|
2015 |
Tan Z, Yin H, Nie S, Lin Z, Zhu J, Ruffin MT, Anderson MA, Simeone DM, Lubman DM. Large-scale identification of core-fucosylated glycopeptide sites in pancreatic cancer serum using mass spectrometry. Journal of Proteome Research. 14: 1968-78. PMID 25732060 DOI: 10.1021/Acs.Jproteome.5B00068 |
0.435 |
|
2015 |
Wang L, Yang H, Abel EV, Ney GM, Palmbos PL, Bednar F, Zhang Y, Leflein J, Waghray M, Owens S, Wilkinson JE, Prasad J, Ljungman M, Rhim AD, Pasca di Magliano M, ... Simeone DM, et al. ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis. Genes & Development. 29: 171-83. PMID 25593307 DOI: 10.1101/Gad.253591.114 |
0.419 |
|
2015 |
Jiang W, Zhang Y, Kane KT, Collins MA, Simeone DM, di Magliano MP, Nguyen KT. CD44 regulates pancreatic cancer invasion through MT1-MMP. Molecular Cancer Research : McR. 13: 9-15. PMID 25566991 DOI: 10.1158/1541-7786.Mcr-14-0076 |
0.418 |
|
2015 |
Chen R, Dawson DW, Pan S, Ottenhof NA, de Wilde RF, Wolfgang CL, May DH, Crispin DA, Lai LA, Lay AR, Waghray M, Wang S, McIntosh MW, Simeone DM, Maitra A, et al. Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma. Laboratory Investigation; a Journal of Technical Methods and Pathology. 95: 43-55. PMID 25347153 DOI: 10.1038/Labinvest.2014.128 |
0.456 |
|
2015 |
Waghray M, Grace G, Yalamanchili M, Wang L, Dziubinski M, Zeinali M, Nagrath S, Simeone D. Abstract PR03: Mesenchymal stem cells in pancreatic cancer possess unique properties in promoting tumor growth and metastasis Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-Pr03 |
0.454 |
|
2015 |
Abel EV, Goto M, Dziubinski ML, Kumar C, Ramanathan N, Simeone DM. Abstract A65: Pancreatic cancer stem cell function is regulated by HNF1A Cancer Research. 75: 2335-2335. DOI: 10.1158/1538-7445.Panca2014-A65 |
0.412 |
|
2015 |
Zhang Y, Mathew E, Mendez F, Flannagan K, Simeone D, Magliano MPD. Abstract LB-205: Myeloid cells are required to establish an immune-suppressive regulatory network in pancreatic cancer by activating the PD-1/PD-L1 checkpoint Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-205 |
0.433 |
|
2015 |
Schofield H, Bednar F, Collins M, Yan W, Zhang Y, Shyam N, Eberle J, Olive K, Bardeesy N, Nakada D, Simeone D, Morrison S, Magliano MPd. Abstract LB-061: Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-061 |
0.431 |
|
2015 |
Zhang Z, Shiratsuchi H, Lin J, Chen G, Reddy RM, Azizi E, Fouladdel S, Chang AC, Lin L, Jiang H, Waghray M, Simeone DM, Wicha MS, Beer DG, Luker G, et al. Abstract 370: Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model Cancer Research. 75: 370-370. DOI: 10.1158/1538-7445.Am2015-370 |
0.39 |
|
2015 |
Pal A, Magliano MPD, Simeone D, Peterson L, Potu H, Talpaz M, Donato N. Abstract 1748: Usp9x as a novel therapeutic target in human pancreatic cancer Cancer Research. 75: 1748-1748. DOI: 10.1158/1538-7445.Am2015-1748 |
0.449 |
|
2015 |
Zeinali M, Murlidhar V, Fouladdel S, Hafner M, Shao S, Azizi E, Wicha MS, Cuneo K, Simeone DM, Nagrath S. Abstract 1595: Analysis of circulating epithelial and EMT-like CTCs in pancreatic cancer using a sensitive microfluidic CTC capture device Cancer Research. 75: 1595-1595. DOI: 10.1158/1538-7445.Am2015-1595 |
0.487 |
|
2015 |
Rivera-Baez L, Lin E, Yoon HJ, Waghray M, Fouladdel S, Azizi E, Wicha M, Simeone D, Nagrath S. Abstract 1594: Application of label-free microfluidic technologies for the enrichment, expansion and characterization of circulating tumor cells in pancreatic cancer Cancer Research. 75: 1594-1594. DOI: 10.1158/1538-7445.Am2015-1594 |
0.49 |
|
2015 |
Lin E, Rivera L, Yoon HJ, Fouladdel S, Wieger J, Guthrie S, Deol YS, Clouthier SG, Luther TK, Simeone DM, Burness ML, Azizi E, Wicha MS, Nagrath S. Abstract 1593: Label-free high throughput microfluidic device for the isolation of circulating tumor cells from breast cancer patients Cancer Research. 75: 1593-1593. DOI: 10.1158/1538-7445.Am2015-1593 |
0.399 |
|
2015 |
Londoño-Joshi AI, Pratt E, Cowan RW, Samuels ML, Kotsopoulos S, Olson J, Long F, Anderson MA, Simeone D, Rhim AD. Abstract 1572: Sensitive and robust targeted sequencing of pancreatic precancer and tumors using microfluidic single-molecule enrichment Cancer Research. 75: 1572-1572. DOI: 10.1158/1538-7445.Am2015-1572 |
0.371 |
|
2014 |
Zhang Z, Shiratsuchi H, Lin J, Chen G, Reddy RM, Azizi E, Fouladdel S, Chang AC, Lin L, Jiang H, Waghray M, Luker G, Simeone DM, Wicha MS, Beer DG, et al. Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model. Oncotarget. 5: 12383-97. PMID 25474037 DOI: 10.18632/Oncotarget.2592 |
0.369 |
|
2014 |
Nie S, Yin H, Tan Z, Anderson MA, Ruffin MT, Simeone DM, Lubman DM. Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric labeling quantitative method. Journal of Proteome Research. 13: 6058-66. PMID 25393578 DOI: 10.1021/Pr500934U |
0.343 |
|
2014 |
Cuneo KC, Chenevert TL, Ben-Josef E, Feng MU, Greenson JK, Hussain HK, Simeone DM, Schipper MJ, Anderson MA, Zalupski MM, Al-Hawary M, Galban CJ, Rehemtulla A, Feng FY, Lawrence TS, et al. A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer. Translational Oncology. 7: 644-9. PMID 25389460 DOI: 10.1016/J.Tranon.2014.07.005 |
0.382 |
|
2014 |
Kim EJ, Sahai V, Abel EV, Griffith KA, Greenson JK, Takebe N, Khan GN, Blau JL, Craig R, Balis UG, Zalupski MM, Simeone DM. Pilot clinical trial of hedgehog pathway inhibitor GDC-0449 (vismodegib) in combination with gemcitabine in patients with metastatic pancreatic adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5937-45. PMID 25278454 DOI: 10.1158/1078-0432.Ccr-14-1269 |
0.418 |
|
2014 |
Murlidhar V, Zeinali M, Grabauskiene S, Ghannad-Rezaie M, Wicha MS, Simeone DM, Ramnath N, Reddy RM, Nagrath S. A radial flow microfluidic device for ultra-high-throughput affinity-based isolation of circulating tumor cells Small. 10: 4895-4904. PMID 25074448 DOI: 10.1002/Smll.201400719 |
0.341 |
|
2014 |
Bednar F, Simeone DM. Recent advances in pancreatic surgery. Current Opinion in Gastroenterology. 30: 518-23. PMID 25010685 DOI: 10.1097/Mog.0000000000000096 |
0.301 |
|
2014 |
Kanwar SS, Dunlay CJ, Simeone DM, Nagrath S. Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes Lab On a Chip. 14: 1891-1900. PMID 24722878 DOI: 10.1039/C4Lc00136B |
0.389 |
|
2014 |
Abel EV, Kim EJ, Wu J, Hynes M, Bednar F, Proctor E, Wang L, Dziubinski ML, Simeone DM. The Notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer. Plos One. 9: e91983. PMID 24647545 DOI: 10.1371/Journal.Pone.0091983 |
0.486 |
|
2014 |
Nie S, Lo A, Wu J, Zhu J, Tan Z, Simeone DM, Anderson MA, Shedden KA, Ruffin MT, Lubman DM. Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis. Journal of Proteome Research. 13: 1873-84. PMID 24571389 DOI: 10.1021/Pr400967X |
0.435 |
|
2014 |
Adler D, Max Schmidt C, Al-Haddad M, Barthel JS, Ljung BM, Merchant NB, Romagnuolo J, Shaaban AM, Simeone D, Bishop Pitman M, Field A, Layfield LJ. Clinical evaluation, imaging studies, indications for cytologic study, and preprocedural requirements for duct brushing studies and pancreatic FNA: the Papanicolaou Society of Cytopathology recommendations for pancreatic and biliary cytology. Diagnostic Cytopathology. 42: 325-32. PMID 24554480 DOI: 10.1002/Dc.23095 |
0.31 |
|
2014 |
Wang L, Yang H, Palmbos PL, Ney G, Detzler TA, Coleman D, Leflein J, Davis M, Zhang M, Tang W, Hicks JK, Helchowski CM, Prasad J, Lawrence TS, Xu L, ... ... Simeone DM, et al. ATDC/TRIM29 phosphorylation by ATM/MAPKAP kinase 2 mediates radioresistance in pancreatic cancer cells. Cancer Research. 74: 1778-88. PMID 24469230 DOI: 10.1158/0008-5472.Can-13-2289 |
0.372 |
|
2014 |
Li L, Hao X, Qin J, Tang W, He F, Smith A, Zhang M, Simeone DM, Qiao XT, Chen ZN, Lawrence TS, Xu L. Antibody against CD44s inhibits pancreatic tumor initiation and postradiation recurrence in mice. Gastroenterology. 146: 1108-18. PMID 24397969 DOI: 10.1053/J.Gastro.2013.12.035 |
0.401 |
|
2014 |
Al-Hawary MM, Francis IR, Chari ST, Fishman EK, Hough DM, Lu DS, Macari M, Megibow AJ, Miller FH, Mortele KJ, Merchant NB, Minter RM, Tamm EP, Sahani DV, Simeone DM. Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association. Gastroenterology. 146: 291-304.e1. PMID 24355035 DOI: 10.1053/J.Gastro.2013.11.004 |
0.364 |
|
2014 |
Al-Hawary MM, Francis IR, Chari ST, Fishman EK, Hough DM, Lu DS, Macari M, Megibow AJ, Miller FH, Mortele KJ, Merchant NB, Minter RM, Tamm EP, Sahani DV, Simeone DM. Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology. 270: 248-60. PMID 24354378 DOI: 10.1148/Radiol.13131184 |
0.364 |
|
2014 |
Michaud NR, Wang Y, McEachern KA, Jordan JJ, Mazzola AM, Hernandez A, Jalla S, Chesebrough JW, Hynes MJ, Belmonte MA, Wang L, Kang JS, Jovanovic J, Laing N, Jenkins DW, ... ... Simeone DM, et al. Novel neutralizing hedgehog antibody MEDI-5304 exhibits antitumor activity by inhibiting paracrine hedgehog signaling. Molecular Cancer Therapeutics. 13: 386-98. PMID 24344235 DOI: 10.1158/1535-7163.Mct-13-0420 |
0.397 |
|
2014 |
Lin Z, Yin H, Lo A, Ruffin MT, Anderson MA, Simeone DM, Lubman DM. Label-free relative quantification of alpha-2-macroglobulin site-specific core-fucosylation in pancreatic cancer by LC-MS/MS. Electrophoresis. 35: 2108-15. PMID 24285556 DOI: 10.1002/Elps.201300376 |
0.357 |
|
2014 |
Palmbos P, Wang L, Yang H, LeFlein J, Wilkinson JE, Kumar-Sinha C, Kunju LP, Daignault S, Wu X, Lotan Y, Liebert M, Ljungman M, Simeone D. Abstract B24: ATDC (Trim29) drives invasive bladder cancer formation Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Modorg-B24 |
0.431 |
|
2014 |
Kanwar SS, Dunlay CJ, Simeone DM, Nagrath S. Abstract 5591: Simultaneous isolation and quantification of circulating exosomes for cancer biomarker discovery Cancer Research. 74: 5591-5591. DOI: 10.1158/1538-7445.Am2014-5591 |
0.428 |
|
2014 |
Pal A, Magliano MPd, Talpaz M, Dziubinski M, Simeone D, Donato NJ. Abstract 4434: Role of Deubiquitinase Usp9x in pancreatic cancers: Tumor promoter or tumor suppressor Cancer Research. 74: 4434-4434. DOI: 10.1158/1538-7445.Am2014-4434 |
0.468 |
|
2014 |
Jack RM, Grafton MM, Cieslak RA, Jue DC, Griffith C, Rodrigues D, Nagrath S, Simeone D. Abstract 3477: Continuous isolation, labeling and collection of viable CTCs using an integrated microfluidic device Cancer Research. 74: 3477-3477. DOI: 10.1158/1538-7445.Am2014-3477 |
0.401 |
|
2014 |
Zhang JZ, Shiratsuchi H, Lin J, Chen G, Reddy RM, Azizi E, Fouladdel S, Chang AC, Lin L, Simeone DM, Wicha MS, Beer DG, Ramnath N, Nagrath S. Abstract 3075:Ex-vivoexpansion of circulating tumor cells in early lung cancer using a microfluidic model Cancer Research. 74: 3075-3075. DOI: 10.1158/1538-7445.Am2014-3075 |
0.427 |
|
2014 |
Murlidhar V, Reddy RM, Zeinali M, Grabauskiene S, Ghannad-Rezaie M, Wicha MS, Simeone DM, Ramnath N, Nagrath S. Abstract 3069: Radial flow microfluidic device for high-throughput affinity-based isolation of circulating tumor cells Cancer Research. 74: 3069-3069. DOI: 10.1158/1538-7445.Am2014-3069 |
0.399 |
|
2014 |
Chen R, Pan S, Maitra A, Simeone D, Dawson D, Brentnall T. Abstract 2866: Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma Cancer Research. 74: 2866-2866. DOI: 10.1158/1538-7445.Am2014-2866 |
0.422 |
|
2014 |
Lee SY, Lloyd WR, Wilson RH, Chandra M, McKenna B, Simeone D, Scheiman J, Mycek MA. Photon-tissue interaction model for quantitative assessment of biological tissues Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8935. DOI: 10.1117/12.2046980 |
0.302 |
|
2014 |
Scheiman J, Wilson RH, Chandra M, Simeone DM, Taylor J, Lee OE, Lloyd WR, Lee SY, Mycek M. Mo1164 Optical Spectroscopy Distinguishes Pancreatic Cancer From Non-Malignant Pancreatic Tissues Gastroenterology. 146: S-574. DOI: 10.1016/S0016-5085(14)62080-1 |
0.421 |
|
2013 |
Lloyd WR, Wilson RH, Lee SY, Chandra M, McKenna B, Simeone D, Scheiman J, Mycek MA. In vivo optical spectroscopy for improved detection of pancreatic adenocarcinoma: a feasibility study. Biomedical Optics Express. 5: 9-15. PMID 24466472 DOI: 10.1364/Boe.5.000009 |
0.372 |
|
2013 |
Lee SY, Lloyd WR, Chandra M, Wilson RH, McKenna B, Simeone D, Scheiman J, Mycek MA. Characterizing human pancreatic cancer precursor using quantitative tissue optical spectroscopy. Biomedical Optics Express. 4: 2828-34. PMID 24409383 DOI: 10.1364/Boe.4.002828 |
0.341 |
|
2013 |
Liddle RA, Freeman M, Simeone DM, Saluja AK, Castillo CF, Maitra A, Pandol SJ, Go VL. Minutes of the business meeting of the American Pancreatic Association, Friday, November 2, 2012, Miami, Florida. Pancreas. 42: 1333-4. PMID 24152959 DOI: 10.1097/Mpa.0B013E3182A99936 |
0.316 |
|
2013 |
Li L, Tang W, Wu X, Karnak D, Meng X, Thompson R, Hao X, Li Y, Qiao XT, Lin J, Fuchs J, Simeone DM, Chen ZN, Lawrence TS, Xu L. HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 6703-15. PMID 24132924 DOI: 10.1158/1078-0432.Ccr-13-0621 |
0.337 |
|
2013 |
Yoon HJ, Kim TH, Zhang Z, Azizi E, Pham TM, Paoletti C, Lin J, Ramnath N, Wicha MS, Hayes DF, Simeone DM, Nagrath S. Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets. Nature Nanotechnology. 8: 735-41. PMID 24077027 DOI: 10.1038/Nnano.2013.194 |
0.36 |
|
2013 |
Bednar F, Scheiman JM, McKenna BJ, Simeone DM. Breast cancer metastases to the pancreas. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 17: 1826-31. PMID 23918083 DOI: 10.1007/S11605-013-2291-5 |
0.33 |
|
2013 |
Waghray M, Yalamanchili M, di Magliano MP, Simeone DM. Deciphering the role of stroma in pancreatic cancer. Current Opinion in Gastroenterology. 29: 537-43. PMID 23892539 DOI: 10.1097/Mog.0B013E328363Affe |
0.447 |
|
2013 |
Zhang Y, Morris JP, Yan W, Schofield HK, Gurney A, Simeone DM, Millar SE, Hoey T, Hebrok M, Pasca di Magliano M. Canonical wnt signaling is required for pancreatic carcinogenesis. Cancer Research. 73: 4909-22. PMID 23761328 DOI: 10.1158/0008-5472.Can-12-4384 |
0.42 |
|
2013 |
Kim EJ, Ben-Josef E, Herman JM, Bekaii-Saab T, Dawson LA, Griffith KA, Francis IR, Greenson JK, Simeone DM, Lawrence TS, Laheru D, Wolfgang CL, Williams T, Bloomston M, Moore MJ, et al. A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer. Cancer. 119: 2692-700. PMID 23720019 DOI: 10.1002/Cncr.28117 |
0.382 |
|
2013 |
Abel EV, Simeone DM. Biology and clinical applications of pancreatic cancer stem cells Gastroenterology. 144: 1241-1248. PMID 23622133 DOI: 10.1053/J.Gastro.2013.01.072 |
0.464 |
|
2013 |
Proctor E, Waghray M, Lee CJ, Heidt DG, Yalamanchili M, Li C, Bednar F, Simeone DM. Bmi1 enhances tumorigenicity and cancer stem cell function in pancreatic adenocarcinoma. Plos One. 8: e55820. PMID 23437065 DOI: 10.1371/Journal.Pone.0055820 |
0.443 |
|
2013 |
Kothari V, Wei I, Shankar S, Kalyana-Sundaram S, Wang L, Ma LW, Vats P, Grasso CS, Robinson DR, Wu YM, Cao X, Simeone DM, Chinnaiyan AM, Kumar-Sinha C. Outlier kinase expression by RNA sequencing as targets for precision therapy. Cancer Discovery. 3: 280-93. PMID 23384775 DOI: 10.1158/2159-8290.Cd-12-0336 |
0.4 |
|
2013 |
Yoon HJ, Kim TH, Zhang Z, Ramnath N, Wicha MS, Hayes DF, Simeone DM, Nagrath S. Abstract 5109: Integrated micro nanotechnology for the sensitive isolation of circulating tumor cells. Cancer Research. 73: 5109-5109. DOI: 10.1158/1538-7445.Am2013-5109 |
0.421 |
|
2013 |
Kumar-Sinha C, Kothari V, Wei I, Shankar S, Kalyana-Sundaram S, Wang L, Ma LW, Vats P, Grasso C, Robinson D, Wu Y, Cao X, Simeone DM, Chinnaiyan AM. Abstract 3136: Sample specific outlier kinase expression identified by RNA-Seq provide targets for precision therapy. Cancer Research. 73: 3136-3136. DOI: 10.1158/1538-7445.Am2013-3136 |
0.372 |
|
2013 |
Palmbos P, Wang L, Yang H, Detzler T, Ney G, Hart J, Daignault-Newton S, Kunju LP, Kumar-Sinha C, Liebert M, Ljungman M, Simeone D. Abstract 313: ATDC drives bladder cancer formation by promoting methylation of the PTEN promoter and inhibition of p53 function. Cancer Research. 73: 313-313. DOI: 10.1158/1538-7445.Am2013-313 |
0.42 |
|
2013 |
Grafton MM, Jack RM, Cieslak R, Rodriguez D, Sharma S, Simeone DM, Nagrath S. Abstract 1457: An integrated microfluidic device for circulating tumor cell detection in pancreatic cancer patients. Cancer Research. 73: 1457-1457. DOI: 10.1158/1538-7445.Am2013-1457 |
0.482 |
|
2013 |
Kothari V, Iris W, Shankar S, Kalyana-Sundaram S, Wang L, Ma LW, Vats P, Grasso CS, Robinson DR, Wu Y, Cao X, Simeone DM, Chinnaiyan AM, Kumar-Sinha C. Abstract PR16: Targeting cancer-specific kinase dependency for precision therapy Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Pms-Pr16 |
0.404 |
|
2013 |
Bednar F, Collins MA, Yan W, Zhang Y, Nakada D, Simeone DM, Morrison SJ, Pasca di Magliano M. Bmi1 is required for murine pancreatic cancer initiation Journal of the American College of Surgeons. 217: S133. DOI: 10.1016/J.Jamcollsurg.2013.07.309 |
0.388 |
|
2012 |
Palmbos PL, Wang L, Yang H, Detzler T, Ney G, Lotan Y, Wilkerson JE, Kunju P, Ljungman M, Liebert M, Simeone DM. ATDC as a novel oncogene in bladder cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 269. PMID 27968252 DOI: 10.1200/Jco.2012.30.5_Suppl.269 |
0.452 |
|
2012 |
Yen WC, Fischer MM, Hynes M, Wu J, Kim E, Beviglia L, Yeung VP, Song X, Kapoun AM, Lewicki J, Gurney A, Simeone DM, Hoey T. Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-Notch signaling in both tumor and vasculature cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5374-86. PMID 22952347 DOI: 10.1158/1078-0432.Ccr-12-0736 |
0.414 |
|
2012 |
Venkatesha VA, Parsels LA, Parsels JD, Zhao L, Zabludoff SD, Simeone DM, Maybaum J, Lawrence TS, Morgan MA. Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition. Neoplasia (New York, N.Y.). 14: 519-25. PMID 22787433 DOI: 10.1593/Neo.12538 |
0.461 |
|
2012 |
Kumar-Sinha C, Wei I, Simeone DM. Emerging frontiers in pancreatic cancer research: Elaboration of key genes, cells and the extracellular milieu Current Opinion in Gastroenterology. 28: 516-522. PMID 22759592 DOI: 10.1097/Mog.0B013E3283567F69 |
0.473 |
|
2012 |
El-Zaatari M, Daignault S, Tessier A, Kelsey G, Travnikar LA, Cantu EF, Lee J, Plonka CM, Simeone DM, Anderson MA, Merchant JL. Plasma Shh levels reduced in pancreatic cancer patients. Pancreas. 41: 1019-28. PMID 22513293 DOI: 10.1097/Mpa.0B013E31824A0Eeb |
0.429 |
|
2012 |
Partyka K, McDonald M, Maupin KA, Brand R, Kwon R, Simeone DM, Allen P, Haab BB. Comparison of surgical and endoscopic sample collection for pancreatic cyst fluid biomarker identification. Journal of Proteome Research. 11: 2904-11. PMID 22439797 DOI: 10.1021/Pr2012736 |
0.311 |
|
2012 |
Bednar F, Simeone DM. Metformin and cancer stem cells: old drug, new targets. Cancer Prevention Research (Philadelphia, Pa.). 5: 351-4. PMID 22389436 DOI: 10.1158/1940-6207.Capr-12-0026 |
0.392 |
|
2012 |
Zhu J, He J, Liu Y, Simeone DM, Lubman DM. Identification of glycoprotein markers for pancreatic cancer CD24+CD44+ stem-like cells using nano-LC-MS/MS and tissue microarray. Journal of Proteome Research. 11: 2272-81. PMID 22335271 DOI: 10.1021/Pr201059G |
0.372 |
|
2012 |
Minter RM, Simeone DM. Contemporary management of nonfunctioning pancreatic neuroendocrine tumors. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 16: 435-46. PMID 22009463 DOI: 10.1007/S11605-011-1693-5 |
0.328 |
|
2012 |
Palmbos PL, Wang L, Yang H, Detzler T, Ney G, Lotan Y, Healy PN, Daignault-Newton S, Kunju P, Kumar C, Ljungman M, Liebert M, Simeone DM. Novel oncogenic function of ATDC in bladder cancer. Journal of Clinical Oncology. 30: 4591-4591. DOI: 10.1200/Jco.2012.30.15_Suppl.4591 |
0.417 |
|
2012 |
Bednar F, Zhang Y, Nakada D, Simeone DM, Morrison SJ, Magliano MPd. Abstract B59: Bmi1 is required for murine pancreatic cancer initiation. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-B59 |
0.438 |
|
2012 |
Wang L, Yang H, Bednar F, Zhang Y, Leflein J, Detzler T, Ney GM, Magliano MPd, Simeone DM. Abstract B49: ATDC synergizes with oncogenic Kras to induce invasive pancreatic adeno-carcinoma in transgenic mice. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-B49 |
0.369 |
|
2012 |
Wang L, Lawrence T, Xu L, Canman C, Ljungman M, Simeone D, Yang H, Palmbos P, Ney G, Detzler TA, Coleman D, Davis M, Hicks K, Helchowski CM. Abstract A93: Radiation-induced phosphorylation of ATDC via ATM/MAPKAP kinase 2 signaling mediates radioresistance of pancreatic cancer cells. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-A93 |
0.408 |
|
2012 |
Kim EJ, Khan GN, Griffith K, Greenson J, Takebe N, Zalupski M, Simeone D. Abstract A40: Cancer stem cells (CSC) and inhibition of hedgehog (Hh) pathway signaling in advanced pancreatic cancer: GDC-0449 in combination with gemcitabine (Gem). Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-A40 |
0.474 |
|
2012 |
Wei I, Kothari V, Shankar S, Kalyana-Sundaram S, Grasso C, Robinson D, Cao X, Simeone D, Chinnaiyan A, Kumar-Sinha C. Abstract A17: Inhibiting polo-like kinases for the treatment of pancreatic cancer: Targeting kinase outliers for personalized therapy. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-A17 |
0.45 |
|
2012 |
Maupin K, Curnutte B, Cao Z, Partyka K, McDonald M, Kwon R, Allen P, Brand R, Simeone D, Haab BB. Abstract 4555: Protein and glycan biomarkers of malignant potential in pancreatic cyst fluid Cancer Research. 72: 4555-4555. DOI: 10.1158/1538-7445.Am2012-4555 |
0.441 |
|
2012 |
Simeone DM, Liddle RA, Chari ST, Saluja AK, Freeman M, Maitra A, Pandol SJ, Go VLW. Minutes of the Business Meeting of the American Pancreatic Association, Friday, November 4, 2011, Chicago, Illinois Pancreas. 41: 1343. DOI: 10.1097/Mpa.0B013E31827083F1 |
0.316 |
|
2011 |
Yue T, Maupin KA, Fallon B, Li L, Partyka K, Anderson MA, Brenner DE, Kaul K, Zeh H, Moser AJ, Simeone DM, Feng Z, Brand RE, Haab BB. Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers. Plos One. 6: e29180. PMID 22220206 DOI: 10.1371/Journal.Pone.0029180 |
0.313 |
|
2011 |
Kwon RS, Simeone DM. The Use of Protein-Based Biomarkers for the Diagnosis of Cystic Tumors of the Pancreas International Journal of Proteomics. 2011: 413646-413646. PMID 22110950 DOI: 10.1155/2011/413646 |
0.337 |
|
2011 |
Bednar F, Simeone DM. Pancreatic cancer stem cell biology and its therapeutic implications. Journal of Gastroenterology. 46: 1345-52. PMID 22048257 DOI: 10.1007/S00535-011-0494-7 |
0.487 |
|
2011 |
Simeone DM. 2011 American Pancreatic Association presidential address: demystifying the pancreas. Pancreas. 40: 1163-1164. PMID 22001829 DOI: 10.1097/Mpa.0B013E3182346Cfb |
0.345 |
|
2011 |
Li C, Wu JJ, Hynes M, Dosch J, Sarkar B, Welling TH, Pasca di Magliano M, Simeone DM. c-Met is a marker of pancreatic cancer stem cells and therapeutic target. Gastroenterology. 141: 2218-2227.e5. PMID 21864475 DOI: 10.1053/J.Gastro.2011.08.009 |
0.419 |
|
2011 |
Kim EJ, Simeone DM. Advances in pancreatic cancer. Current Opinion in Gastroenterology. 27: 460-466. PMID 21778878 DOI: 10.1097/Mog.0B013E328349E31F |
0.474 |
|
2011 |
Li C, Zolotarevsky E, Thompson I, Anderson MA, Simeone DM, Casper JM, Mullenix MC, Lubman DM. A multiplexed bead assay for profiling glycosylation patterns on serum protein biomarkers of pancreatic cancer. Electrophoresis. 32: 2028-35. PMID 21732554 DOI: 10.1002/Elps.201000693 |
0.41 |
|
2011 |
Parsels LA, Qian Y, Tanska DM, Gross M, Zhao L, Hassan MC, Arumugarajah S, Parsels JD, Hylander-Gans L, Simeone DM, Morosini D, Brown JL, Zabludoff SD, Maybaum J, Lawrence TS, et al. Assessment of chk1 phosphorylation as a pharmacodynamic biomarker of chk1 inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3706-15. PMID 21482692 DOI: 10.1158/1078-0432.Ccr-10-3082 |
0.459 |
|
2011 |
Lin Z, Simeone DM, Anderson MA, Brand RE, Xie X, Shedden KA, Ruffin MT, Lubman DM. Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer. Journal of Proteome Research. 10: 2602-11. PMID 21417406 DOI: 10.1021/Pr200102H |
0.445 |
|
2011 |
Yue T, Maupin K, Partyka K, Li L, Anderson MA, Brenner D, Simeone D, Feng Z, Brand RE, Haab BB. Abstract 2216: Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers Cancer Research. 71: 2216-2216. DOI: 10.1158/1538-7445.Am2011-2216 |
0.326 |
|
2011 |
Wilson RH, Chandra M, Lloyd W, Chen LC, Scheiman J, Simeone D, McKenna B, Mycek MA. Optical spectroscopy for quantitative sensing in human pancreatic tissues Optics Infobase Conference Papers. DOI: 10.1117/12.889724 |
0.356 |
|
2011 |
Chari ST, Simeone DM, Warshaw AL, Saluja AK, Freeman M, Liddle RA, Pandol SJ, Go VLW. Minutes of the Business Meeting of the American Pancreatic Association Friday, November 5, 2010, Chicago, Illinois Pancreas. 40: 1307. DOI: 10.1097/Mpa.0B013E3182334Ed9 |
0.316 |
|
2011 |
Proctor EN, Wu J, Hynes MJ, Dosch J, Simeone DM. Inhibition Of The Notch Signaling Pathway Targets Cancer Stem Cells In Pancreatic Ductal Adenocarcinoma Journal of Surgical Research. 165: 303. DOI: 10.1016/J.Jss.2010.11.354 |
0.409 |
|
2011 |
Ben-Josef E, Schipper M, Francis I, Khan G, Hadley S, Lawrence T, Simeone D, Abrams R, Sonnenday C, Zalupski M. Phase I/II Radiation Dose-Escalation Trial of Intensity Modulated Radiotherapy (IMRT) with Concurrent Fixed Dose-Rate Gemcitabine (FDR-G) for Unresectable Pancreatic Cancer International Journal of Radiation Oncology*Biology*Physics. 81: S127-S128. DOI: 10.1016/J.Ijrobp.2011.06.263 |
0.3 |
|
2010 |
Li C, Kim HY, Vuong H, Patwa T, Pal M, Brand RE, Simeone DM, Lubman DM. The identification of auto-antibodies in pancreatic cancer patient sera using a naturally fractionated Panc-1 cell line. Cancer Biomarkers : Section a of Disease Markers. 7: 25-37. PMID 21045262 DOI: 10.3233/Cbm-2010-0145 |
0.464 |
|
2010 |
Wilson RH, Chandra M, Chen LC, Lloyd WR, Scheiman J, Simeone D, Purdy J, McKenna B, Mycek MA. Photon-tissue interaction model enables quantitative optical analysis of human pancreatic tissues. Optics Express. 18: 21612-21. PMID 20941059 DOI: 10.1364/Oe.18.021612 |
0.317 |
|
2010 |
Anderson MA, Brenner DE, Scheiman JM, Simeone DM, Singh N, Sikora MJ, Zhao L, Mertens AN, Rae JM. Reliable gene expression measurements from fine needle aspirates of pancreatic tumors: effect of amplicon length and quality assessment. The Journal of Molecular Diagnostics : Jmd. 12: 566-75. PMID 20709792 DOI: 10.2353/Jmoldx.2010.090107 |
0.361 |
|
2010 |
Lee CJ, Spalding AC, Ben-Josef E, Wang L, Simeone DM. In vivo bioluminescent imaging of irradiated orthotopic pancreatic cancer xenografts in nonobese diabetic-severe combined immunodeficient mice: a novel method for targeting and assaying efficacy of ionizing radiation. Translational Oncology. 3: 153-9. PMID 20563256 DOI: 10.1593/Tlo.09184 |
0.404 |
|
2010 |
Morgan MA, Parsels LA, Zhao L, Parsels JD, Davis MA, Hassan MC, Arumugarajah S, Hylander-Gans L, Morosini D, Simeone DM, Canman CE, Normolle DP, Zabludoff SD, Maybaum J, Lawrence TS. Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair. Cancer Research. 70: 4972-81. PMID 20501833 DOI: 10.1158/0008-5472.Can-09-3573 |
0.326 |
|
2010 |
Dai L, Li C, Shedden KA, Lee CJ, Li C, Quoc H, Simeone DM, Lubman DM. Quantitative proteomic profiling studies of pancreatic cancer stem cells. Journal of Proteome Research. 9: 3394-402. PMID 20486718 DOI: 10.1021/Pr100231M |
0.448 |
|
2010 |
Dosch JS, Pasca di Magliano M, Simeone DM. Pancreatic cancer and hedgehog pathway signaling: new insights. Pancreatology : Official Journal of the International Association of Pancreatology (Iap) ... [Et Al.]. 10: 151-7. PMID 20453550 DOI: 10.1159/000225923 |
0.398 |
|
2010 |
Haab BB, Porter A, Yue T, Li L, Scheiman J, Anderson MA, Barnes D, Schmidt CM, Feng Z, Simeone DM. Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms. Annals of Surgery. 251: 937-45. PMID 20395854 DOI: 10.1097/Sla.0B013E3181D7738D |
0.366 |
|
2010 |
Chandra M, Scheiman J, Simeone D, McKenna B, Purdy J, Mycek MA. Spectral areas and ratios classifier algorithm for pancreatic tissue classification using optical spectroscopy. Journal of Biomedical Optics. 15: 010514. PMID 20210425 DOI: 10.1117/1.3314900 |
0.355 |
|
2010 |
Khan GN, di Magliano MP, Simeone DM. New Frontiers in Pancreatic Cancer Research Surgical Oncology Clinics of North America. 19: 431-451. PMID 20159524 DOI: 10.1016/J.Soc.2009.11.010 |
0.414 |
|
2010 |
Patwa T, Li C, Simeone DM, Lubman DM. Glycoprotein analysis using protein microarrays and mass spectrometry. Mass Spectrometry Reviews. 29: 830-44. PMID 20077480 DOI: 10.1002/Mas.20269 |
0.326 |
|
2010 |
Pausawasdi N, Heidt D, Kwon R, Simeone D, Scheiman J. Long-term follow-up of patients with incidentally discovered pancreatic cystic neoplasms evaluated by endoscopic ultrasound Surgery. 147: 13-20. PMID 19767045 DOI: 10.1016/J.Surg.2009.05.014 |
0.342 |
|
2010 |
Wilson RH, Chandra M, Lloyd W, Scheiman J, Simeone D, Purdy J, McKenna B, Mycek M. Quantitative optical spectroscopy for pancreatic cancer detection Ieee Transactions On Biomedical Engineering. DOI: 10.1364/Biomed.2010.Bwb6 |
0.361 |
|
2010 |
Li C, Hynes M, Dosch J, Wu J, Sarkar B, Magliano MPd, Simeone DM. Abstract LB-257: c-Met: a new cancer stem cell marker and therapeutic target for pancreatic cancer Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-257 |
0.451 |
|
2010 |
Parsels LA, Morgan MA, Tanska DM, Parsels JD, Davis MA, Hassan MC, Arumugarajah S, Hylander-Gans L, Morosini D, Zhao L, Simeone DM, Canman CE, Normolle DP, Zabludoff SD, Lawrence TS, et al. Abstract 1765: Preclinical optimization of the Chk1/2 inhibitor AZD7762 in combination with gemcitabine in pancreatic cancer Cancer Research. 70: 1765-1765. DOI: 10.1158/1538-7445.Am10-1765 |
0.484 |
|
2010 |
Warshaw AL, Chari ST, Logsdon CD, Saluja AK, Freeman M, Liddle RA, Simeone DM, Go VLW. Minutes of the Business Meeting of the American Pancreatic Association, Friday, November 6, 2009, Honolulu, Hawaii Pancreas. 39: 1305. DOI: 10.1097/Mpa.0B013E3181F7064D |
0.317 |
|
2009 |
Wilson RH, Chandra M, Scheiman J, Simeone D, McKenna B, Purdy J, Mycek MA. Optical spectroscopy detects histological hallmarks of pancreatic cancer. Optics Express. 17: 17502-16. PMID 19907534 DOI: 10.1364/Oe.17.017502 |
0.358 |
|
2009 |
Philip PA, Mooney M, Jaffe D, Eckhardt G, Moore M, Meropol N, Emens L, O'Reilly E, Korc M, Ellis L, Benedetti J, Rothenberg M, Willett C, Tempero M, Lowy A, ... ... Simeone D, et al. Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5660-9. PMID 19858397 DOI: 10.1200/Jco.2009.21.9022 |
0.436 |
|
2009 |
Patwa TH, Li C, Poisson LM, Kim HY, Pal M, Ghosh D, Simeone DM, Lubman DM. The identification of phosphoglycerate kinase-1 and histone H4 autoantibodies in pancreatic cancer patient serum using a natural protein microarray. Electrophoresis. 30: 2215-26. PMID 19582723 DOI: 10.1002/Elps.200800857 |
0.457 |
|
2009 |
Li C, Lee CJ, Simeone DM. Identification of human pancreatic cancer stem cells. Methods of Molecular Biology. 568: 161-173. PMID 19582426 DOI: 10.1007/978-1-59745-280-9_10 |
0.48 |
|
2009 |
Brand RE, Greer JB, Zolotarevsky E, Brand R, Du H, Simeone D, Zisman A, Gorchow A, Lee SC, Roy HK, Anderson MA. Pancreatic Cancer Patients Who Smoke and Drink Are Diagnosed at Younger Ages Clinical Gastroenterology and Hepatology. 7: 1007-1012. PMID 19560558 DOI: 10.1016/J.Cgh.2009.06.008 |
0.308 |
|
2009 |
Sarkar B, Dosch J, Simeone DM. Cancer Stem Cells: A New Theory Regarding a Timeless Disease Chemical Reviews. 109: 3200-3208. PMID 19522504 DOI: 10.1021/Cr9000397 |
0.342 |
|
2009 |
Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, Huang E, Finlayson E, Simeone D, Welling TH, Chang A, Coukos G, Liu R, Zou W. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood. 114: 1141-9. PMID 19470694 DOI: 10.1182/Blood-2009-03-208249 |
0.341 |
|
2009 |
Desai S, Ben-Josef E, Griffith KA, Simeone D, Greenson JK, Francis IR, Hampton J, Colletti L, Chang AE, Lawrence TS, Zalupski MM. Gemcitabine-based combination chemotherapy followed by radiation with capecitabine as adjuvant therapy for resected pancreas cancer. International Journal of Radiation Oncology, Biology, Physics. 75: 1450-5. PMID 19409732 DOI: 10.1016/J.Ijrobp.2009.01.023 |
0.31 |
|
2009 |
Kryczek I, Liu R, Wang G, Wu K, Shu X, Szeliga W, Vatan L, Finlayson E, Huang E, Simeone D, Redman B, Welling TH, Chang A, Zou W. FOXP3 defines regulatory T cells in human tumor and autoimmune disease. Cancer Research. 69: 3995-4000. PMID 19383912 DOI: 10.1158/0008-5472.Can-08-3804 |
0.316 |
|
2009 |
Bednar F, Simeone DM. Pancreatic cancer stem cells and relevance to cancer treatments. Journal of Cellular Biochemistry. 107: 40-5. PMID 19301275 DOI: 10.1002/Jcb.22093 |
0.471 |
|
2009 |
Wang L, Heidt DG, Lee CJ, Yang H, Logsdon CD, Zhang L, Fearon ER, Ljungman M, Simeone DM. Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization. Cancer Cell. 15: 207-19. PMID 19249679 DOI: 10.1016/J.Ccr.2009.01.018 |
0.462 |
|
2009 |
Li C, Simeone DM, Brenner DE, Anderson MA, Shedden KA, Ruffin MT, Lubman DM. Pancreatic cancer serum detection using a lectin/glyco-antibody array method. Journal of Proteome Research. 8: 483-92. PMID 19072160 DOI: 10.1021/Pr8007013 |
0.411 |
|
2009 |
Logsdon CD, Warshaw AL, Forsmark CE, Saluja AK, Chari ST, Liddle RA, Simeone DM, Go VLW. Minutes of the Business Meeting of the American Pancreatic Association Thursday, November 6, 2008, Chicago, Illinois Pancreas. 38: 979. DOI: 10.1097/Mpa.0B013E3181Bd176B |
0.316 |
|
2009 |
Lee C, Dosch J, Wang L, Ljungman M, Simeone D. PL4. Expression of ATDC in Pancreatic Cancer Stem Cells Confers Resistance to DNA Damage Journal of Surgical Research. 151: 227. DOI: 10.1016/J.Jss.2008.11.135 |
0.393 |
|
2008 |
Simeone DM. Pancreatic Cancer Stem Cells: Implications for the Treatment of Pancreatic Cancer Clinical Cancer Research. 14: 5646-5648. PMID 18794070 DOI: 10.1158/1078-0432.Ccr-08-0584 |
0.489 |
|
2008 |
Grote T, Siwak DR, Fritsche HA, Joy C, Mills GB, Simeone D, Whitcomb DC, Logsdon CD. Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: Accurate detection of CA19-9 levels in pancreatic cancer Proteomics. 8: 3051-3060. PMID 18615426 DOI: 10.1002/Pmic.200700951 |
0.302 |
|
2008 |
Lee CJ, Li C, Simeone DM. Human pancreatic cancer stem cells: implications for how we treat pancreatic cancer. Translational Oncology. 1: 14-18. PMID 18607507 DOI: 10.1593/Tlo.08013 |
0.489 |
|
2008 |
Lee CJ, Dosch J, Simeone DM. Pancreatic Cancer Stem Cells Journal of Clinical Oncology. 26: 2806-2812. PMID 18539958 DOI: 10.1200/Jco.2008.16.6702 |
0.478 |
|
2008 |
Patwa TH, Wang Y, Simeone DM, Lubman DM. Enhanced detection of autoantibodies on protein microarrays using a modified protein digestion technique. Journal of Proteome Research. 7: 2553-61. PMID 18452326 DOI: 10.1021/Pr800023G |
0.355 |
|
2008 |
Simeone DM. SSAT/AGA/ASGE state of the art conference on cystic neoplasms of the pancreas. Journal of Gastrointestinal Surgery. 12: 1475-1477. PMID 18224378 DOI: 10.1007/S11605-007-0351-4 |
0.311 |
|
2008 |
Lee CJ, Scheiman J, Anderson MA, Hines OJ, Reber HA, Farrell J, Kochman ML, Foley PJ, Drebin J, Oh YS, Ginsberg G, Ahmad N, Merchant NB, Isbell J, Parikh AA, ... ... Simeone DM, et al. Risk of malignancy in resected cystic tumors of the pancreas < or =3 cm in size: is it safe to observe asymptomatic patients? A multi-institutional report. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 12: 234-42. PMID 18040749 DOI: 10.1007/S11605-007-0381-Y |
0.356 |
|
2008 |
Wilson RH, Chandra M, Scheiman J, Heidt D, Simeone D, McKenna B, Mycek M. Modeling Reflectance and Fluorescence Spectra of Human Pancreatic Tissues for Cancer Diagnostics Frontiers in Optics. DOI: 10.1364/Fio.2008.Ftuk5 |
0.385 |
|
2008 |
Urrutia RA, Logsdon CD, Forsmark CE, Saluja AK, Chari ST, Simeone DM, Warshaw AL, Go VLW. Minutes of the Business Meeting of the American Pancreatic Association Friday, November 2, 2007, Chicago, Illinois Pancreas. 37: 454-455. DOI: 10.1097/Mpa.0B013E31818De01F |
0.316 |
|
2008 |
Haab BB, Porter A, Schmidt M, Lee CJ, Barnes D, Simeone D. GLYCOSYLATION VARIANTS ON MUCINS AS CANDIDATE MARKERS FOR THE DIAGNOSIS OF PANCREATIC CYSTIC NEOPLASMS Pancreas. 37: 472-473. DOI: 10.1097/01.Mpa.0000335466.30936.C1 |
0.353 |
|
2008 |
Barnes D, Wang L, Ljungman M, Simeone D. 203. ATDC, A Novel DNA Damage Response Protein, Is Highly Expressed in Pancreatic Cancer Journal of Surgical Research. 144: 267-268. DOI: 10.1016/J.Jss.2007.12.231 |
0.388 |
|
2008 |
Lee CJ, Simeone DM, Lee C, Zielske S, Dosch J, Ljungman M. 140. Pancreatic Cancer Stem Cells are Resistant to Ionizing Radiation and the Chemotherapeutic Agent Gemcitabine Journal of Surgical Research. 144: 238. DOI: 10.1016/J.Jss.2007.12.159 |
0.397 |
|
2007 |
Chandra M, Scheiman J, Heidt D, Simeone D, McKenna B, Mycek MA. Probing pancreatic disease using tissue optical spectroscopy. Journal of Biomedical Optics. 12: 060501. PMID 18163796 DOI: 10.1117/1.2818029 |
0.401 |
|
2007 |
Misek DE, Patwa TH, Lubman DM, Simeone DM. Early detection and biomarkers in pancreatic cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 5: 1034-41. PMID 18053427 DOI: 10.6004/Jnccn.2007.0086 |
0.442 |
|
2007 |
Desai SP, Ben-Josef E, Normolle DP, Francis IR, Greenson JK, Simeone DM, Chang AE, Colletti LM, Lawrence TS, Zalupski MM. Phase I study of oxaliplatin, full-dose gemcitabine, and concurrent radiation therapy in pancreatic cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 4587-92. PMID 17925553 DOI: 10.1200/Jco.2007.12.0592 |
0.326 |
|
2007 |
Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli C, Clarke MF. Phenotypic characterization of human colorectal cancer stem cells. Proceedings of the National Academy of Sciences of the United States of America. 104: 10158-63. PMID 17548814 DOI: 10.1073/Pnas.0703478104 |
0.428 |
|
2007 |
Simeone DM, Ji B, Banerjee M, Arumugam T, Li D, Anderson MA, Bamberger AM, Greenson J, Brand RE, Ramachandran V, Logsdon CD. CEACAM1, a novel serum biomarker for pancreatic cancer. Pancreas. 34: 436-43. PMID 17446843 DOI: 10.1097/Mpa.0B013E3180333Ae3 |
0.441 |
|
2007 |
Chen J, Anderson M, Misek DE, Simeone DM, Lubman DM. Characterization of apolipoprotein and apolipoprotein precursors in pancreatic cancer serum samples via two-dimensional liquid chromatography and mass spectrometry. Journal of Chromatography. A. 1162: 117-25. PMID 17434173 DOI: 10.1016/J.Chroma.2007.03.096 |
0.336 |
|
2007 |
Zhao J, Patwa TH, Qiu W, Shedden K, Hinderer R, Misek DE, Anderson MA, Simeone DM, Lubman DM. Glycoprotein microarrays with multi-lectin detection: unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera. Journal of Proteome Research. 6: 1864-74. PMID 17428079 DOI: 10.1021/Pr070062P |
0.483 |
|
2007 |
Heidt DG, Burant C, Simeone DM. Total pancreatectomy: indications, operative technique, and postoperative sequelae. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 11: 209-16. PMID 17390175 DOI: 10.1007/S11605-006-0025-7 |
0.363 |
|
2007 |
Huang EH, Heidt DG, Li CW, Simeone DM. Cancer stem cells: a new paradigm for understanding tumor progression and therapeutic resistance. Surgery. 141: 415-419. PMID 17383517 DOI: 10.1016/J.Surg.2006.12.015 |
0.392 |
|
2007 |
Ramachandran V, Arumugam T, Hwang RF, Greenson JK, Simeone DM, Logsdon CD. Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR. Cancer Research. 67: 2666-75. PMID 17363587 DOI: 10.1158/0008-5472.Can-06-3362 |
0.465 |
|
2007 |
Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM. Identification of pancreatic cancer stem cells Cancer Research. 67: 1030-1037. PMID 17283135 DOI: 10.1158/0008-5472.Can-06-2030 |
0.464 |
|
2007 |
Zhao J, Qiu W, Simeone DM, Lubman DM. N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis. Journal of Proteome Research. 6: 1126-38. PMID 17249709 DOI: 10.1021/Pr0604458 |
0.389 |
|
2007 |
Yue T, Chen S, Goldstein I, Hollingsworth MA, Simeone D, Brand RE, Haab BB. PROFILING GLYCAN STRUCTURES ON MUCINS IN THE SERA OF PANCREATIC CANCER PATIENTS USING ANTIBODY ARRAYS Pancreas. 35: 437-438. DOI: 10.1097/01.Mpa.0000297820.29441.D1 |
0.386 |
|
2007 |
Wang L, Lee CJ, Heidt DG, Ljungman ME, Simeone DM. ATDC, A HIGHLY EXPRESSED PROTEIN IN PANCREATIC CANCER, CONTRIBUTES TO TUMORIGENICITY BY UPREGULATING WNT/β-CATENIN SIGNALING Pancreas. 35: 434. DOI: 10.1097/01.Mpa.0000297808.26412.87 |
0.374 |
|
2007 |
Zolotarevsky E, Kwon RS, Piraka CR, Wamsteker EJ, Elta GH, Simeone DM, Scheiman J, Pedroza JM, Anderson MA. Endoscopic Ultrasound with Fine Needle Aspiration (EUS-FNA) with Pancreatic Cyst Fluid DNA Analysis Influences Clinical Management in Patients with Cystic Lesions of the Pancreas Gastrointestinal Endoscopy. 65. DOI: 10.1016/J.Gie.2007.03.363 |
0.306 |
|
2006 |
Hong SH, Misek DE, Wang H, Puravs E, Hinderer R, Giordano TJ, Greenson JK, Brenner DE, Simeone DM, Logsdon CD, Hanash SM. Identification of a Specific Vimentin Isoform That Induces an Antibody Response in Pancreatic Cancer. Biomarker Insights. 1: 175-183. PMID 18769604 |
0.39 |
|
2006 |
Patwa TH, Zhao J, Anderson MA, Simeone DM, Lubman DM. Screening of glycosylation patterns in serum using natural glycoprotein microarrays and multi-lectin fluorescence detection. Analytical Chemistry. 78: 6411-21. PMID 16970316 DOI: 10.1021/Ac060726Z |
0.375 |
|
2006 |
Zhao J, Simeone DM, Heidt D, Anderson MA, Lubman DM. Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: application to pancreatic cancer serum. Journal of Proteome Research. 5: 1792-802. PMID 16823988 DOI: 10.1021/Pr060034R |
0.362 |
|
2006 |
Newman EA, Simeone DM, Mulholland MW. Adjuvant treatment strategies for pancreatic cancer. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 10: 916-26. PMID 16769552 DOI: 10.1016/J.Gassur.2005.10.018 |
0.453 |
|
2006 |
Simeone DM, Zhang L, Treutelaar MK, Zhang L, Graziano K, Logsdon CD, Burant CF. Islet hypertrophy following pancreatic disruption of Smad4 signaling. American Journal of Physiology. Endocrinology and Metabolism. 291: E1305-16. PMID 16735447 DOI: 10.1152/Ajpendo.00561.2005 |
0.307 |
|
2006 |
Zhang L, Chenwei L, Mahmood R, van Golen K, Greenson J, Li G, D'Silva NJ, Li X, Burant CF, Logsdon CD, Simeone DM. Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer. Cancer Research. 66: 898-906. PMID 16424023 DOI: 10.1158/0008-5472.Can-05-3025 |
0.489 |
|
2006 |
Desai SP, Ben-Josef E, Lawrence TJ, Francis IR, Greenson JK, Alfred CE, Colletti LM, Simeone DM, Normolle DP, Zalupski MM. A phase I study of oxaliplatin, full-dose gemcitabine and concurrent radiation therapy in patients with pancreatic cancer Journal of Clinical Oncology. 24: 4107-4107. DOI: 10.1200/Jco.2006.24.18_Suppl.4107 |
0.306 |
|
2006 |
Heidt DG, Li C, Mollenberg N, Clarke MF, Simeone D. Identification of pancreatic cancer stem cells Journal of Surgical Research. 130: 194-195. DOI: 10.1016/J.Jss.2005.11.093 |
0.448 |
|
2006 |
Lee C, Zhang L, Uhler M, Simeone D. A TGFβ-induced Smad complex directly activates PKA in pancreatic acinar cells and regulates pancreatic acinar cell growth Journal of Surgical Research. 130: 171. DOI: 10.1016/J.Jss.2005.11.030 |
0.385 |
|
2005 |
Arumugam T, Simeone DM, Van Golen K, Logsdon CD. S100P promotes pancreatic cancer growth, survival, and invasion. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 5356-64. PMID 16061848 DOI: 10.1158/1078-0432.CCR-05-0092 |
0.329 |
|
2005 |
Zhang L, Heidt DG, Simeone DM, Burant CF. Prospective Identification Of Adult Pancreatic Stem/Progenitor Cells Pancreas. 31: 480. DOI: 10.1097/01.Mpa.0000193801.74497.D3 |
0.321 |
|
2005 |
Li C, Heidt DG, Mollenberg N, Clarke M, Simeone DM. Identification Of Pancreatic Cancer Stem Cells Pancreas. 31: 452. DOI: 10.1097/01.Mpa.0000193704.00116.C2 |
0.448 |
|
2005 |
Heidt D, Birkmeyer JD, Sun Y, Ben-Josef E, Simeone DM. Effect Of Adjuvant Radiation Treatment On Survival Following Pancreaticoduodenectomy For Pancreatic Cancer: A Population-Based Study Pancreas. 31: 446. DOI: 10.1097/01.Mpa.0000193684.67835.6B |
0.375 |
|
2005 |
Simeone DM. Pancreatic Cancer: Methods and Protocols Gastroenterology. 129: 1136. DOI: 10.1053/J.Gastro.2005.07.035 |
0.435 |
|
2005 |
Anderson M, Ji B, Scheiman JM, Song J, Weinman BM, Simeone D, Logsdon C. Molecular Markers From EUS Fine Needle Specimens Can Differentiate Pancreatic Neoplasia Requiring Surgery From Chronic Pancreatitis and Other Benign Conditions of the Pancreas Gastrointestinal Endoscopy. 61. DOI: 10.1016/S0016-5107(05)00594-8 |
0.351 |
|
2004 |
Binkley CE, Zhang L, Greenson JK, Giordano TJ, Kuick R, Misek D, Hanash S, Logsdon CD, Simeone DM. The molecular basis of pancreatic fibrosis: common stromal gene expression in chronic pancreatitis and pancreatic adenocarcinoma. Pancreas. 29: 254-63. PMID 15502640 DOI: 10.1097/00006676-200411000-00003 |
0.434 |
|
2004 |
Hong SH, Misek DE, Wang H, Puravs E, Giordano TJ, Greenson JK, Brenner DE, Simeone DM, Logsdon CD, Hanash SM. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer. Cancer Research. 64: 5504-10. PMID 15289361 DOI: 10.1158/0008-5472.Can-04-0077 |
0.492 |
|
2004 |
Okami J, Simeone DM, Logsdon CD. Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer. Cancer Research. 64: 5338-46. PMID 15289340 DOI: 10.1158/0008-5472.Can-04-0089 |
0.455 |
|
2004 |
Ji B, Anderson M, Song J, Simeone D, Weinman B, Scheiman J, Logsdon CD. Pancreatic Cancer Associated Gene Expression From Fna Samples Differentiates Neoplastic From Benign Pancreatic Diseases. Pancreas. 29: 337. DOI: 10.1097/00006676-200411000-00054 |
0.43 |
|
2004 |
Arumugam T, Simeone DM, Logsdon CD. S100P Increases Pancreatic Cancer Growth And Invasion. Pancreas. 29: 333. DOI: 10.1097/00006676-200411000-00040 |
0.411 |
|
2004 |
Ramachandran V, Arimugam T, Li G, Logsdon CD, Simeone DM. Adrenomedullin Is Overexpressed In Pancreatic Cancer And Stimulates Cell Growth And Invasion. Pancreas. 29: 331. DOI: 10.1097/00006676-200411000-00034 |
0.431 |
|
2003 |
Shedden KA, Taylor JM, Giordano TJ, Kuick R, Misek DE, Rennert G, Schwartz DR, Gruber SB, Logsdon C, Simeone D, Kardia SL, Greenson JK, Cho KR, Beer DG, Fearon ER, et al. Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based framework. The American Journal of Pathology. 163: 1985-95. PMID 14578198 DOI: 10.1016/S0002-9440(10)63557-2 |
0.33 |
|
2003 |
Treutelaar MK, Skidmore JM, Dias-Leme CL, Hara M, Zhang L, Simeone D, Martin DM, Burant CF. Nestin-lineage cells contribute to the microvasculature but not endocrine cells of the islet. Diabetes. 52: 2503-12. PMID 14514633 DOI: 10.2337/Diabetes.52.10.2503 |
0.342 |
|
2003 |
Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ, Misek DE, Kuick R, Hanash S. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Research. 63: 2649-57. PMID 12750293 |
0.368 |
|
2003 |
Arumugam T, Simeone D, Logsdon C. S100P is expressed in pancreatic adenocarcinoma and stimulates pancreatic cancer cell proliferation and survival Gastroenterology. 124. DOI: 10.1016/S0016-5085(03)81457-9 |
0.396 |
|
2003 |
Okami J, Arumugam T, Simeone D, Logsdon C. Genes down-regulated in pancreatic adenocarcinoma affect cell survival: Reintroduction of proapoptotic BNIP3 leads to cancer cell death Gastroenterology. 124. DOI: 10.1016/S0016-5085(03)80101-4 |
0.417 |
|
2003 |
Binkley CE, Davis MA, Zhang L, Lawrence TS, Logsdon CD, Simeone DM. The ataxia telangiectasia group D associated gene confers a cellular survival advantage in pancreatic adenocarcinoma Journal of Surgical Research. 114: 240. DOI: 10.1016/J.Jss.2003.08.131 |
0.377 |
|
2002 |
Ji B, Bi Y, Simeone D, Mortensen RM, Logsdon CD. Human pancreatic acinar cells do not respond to cholecystokinin. Pharmacology & Toxicology. 91: 327-32. PMID 12688376 DOI: 10.1034/J.1600-0773.2002.910610.X |
0.308 |
|
2002 |
Burant CF, Simeone DM. Connecting islet development and developing useful islets. Trends in Endocrinology and Metabolism: Tem. 13: 48-9. PMID 11854014 DOI: 10.1016/S1043-2760(01)00555-0 |
0.356 |
|
2001 |
Ji B, Bi Y, Simeone D, Mortensen RM, Logsdon CD. Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin. Gastroenterology. 121: 1380-90. PMID 11729117 DOI: 10.1053/Gast.2001.29557 |
0.333 |
|
2001 |
Zhang L, Vanleeuwen K, Surg G, Logsdon CD, Simeone DM. TGFβ activation of cAMP responsive element-binding protein (CREB) is dependent on PKA and smads in pancreatic acinar cells Gastroenterology. 120. DOI: 10.1016/S0016-5085(08)81731-3 |
0.313 |
|
2000 |
Simeone DM, Pham T, Logsdon CD. Disruption of TGFbeta signaling pathways in human pancreatic cancer cells. Annals of Surgery. 232: 73-80. PMID 10862198 DOI: 10.1097/00000658-200007000-00011 |
0.411 |
|
2000 |
Zhang L, Logsdon CD, Simeone DM. TGFB-mediated growth inhibition and induction of P21 in pancreatic acinar cells is blocked by adenoviral gene transfer of dominant negative DPC4 Gastroenterology. 118. DOI: 10.1016/S0016-5085(00)84977-X |
0.307 |
|
2000 |
vanLeeuwen K, Zhang L, Han B, Logsdon CD, Simeone DM. Transcription factor activation by TGFB in pancreatic acinar cells: role of DPC4 and map kinases Gastroenterology. 118. DOI: 10.1016/S0016-5085(00)83898-6 |
0.309 |
|
2000 |
vanLeeuwen K, Pham T, Logsdon CD, Simeone DM. TGFb inhibits growth in a human pancreatic cancer cell line lacking DPC4 Gastroenterology. 118. DOI: 10.1016/S0016-5085(00)81551-6 |
0.413 |
|
1997 |
Simeone DM, Cascarelli A, Logsdon CD. Adenoviral-mediated gene transfer of a constitutively active retinoblastoma gene inhibits human pancreatic tumor cell proliferation Surgery. 122: 428-434. PMID 9288150 DOI: 10.1016/S0039-6060(97)90036-2 |
0.453 |
|
Show low-probability matches. |